Loss of heterozygosity at the 5,10-methylenetetrahydrofolate reductase locus in human ovarian carcinomas

British Journal of Cancer

Volumn 75, Issue 8, 1997, Pages 1105-1110

  Viel, A ^a   Dall'Agnese, L ^a   Simone, F ^a   Canzonieri, V ^a   Capozzi, E ^a   Visentin, M C ^a   Valle, R ^a   Boiocchi, M ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

5,10 methylenetetrahydrofolate reductase; Folate; Folate binding protein; Loss of heterozygosity; Ovarian carcinoma

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ARTICLE; CANCER GENETICS; CHROMOSOME 1P; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FOLATE METABOLISM; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL;

EID: 0030993597     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.191     Document Type: Article

References (35)

1. Antony AC (1992) The biological chemistry of folate receptors. Blood 79: 2807-2820
2. Campbell IG, Jones TA, Foulkes WD and Trowsdale J (1991) Folate-binding protein is a marker for ovarian cancer. Cancer Res 51: 5329-5338
3. Chenevix Trench G, Leary J, Kerr J, Michel J, Kefford R, Hurst T, Parsons PG, Friedlander M and Khoo SK (1992) Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus. Oncogene 7: 1059-1065
4. Chomczynsky P and Sacchi N (1987) Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159
5. Cliby W, Ritland S, Hartmann L, Dodson M, Halling KC, Keeney G, Podratz KC and Jenkins RB (1993) Human epithelial ovarian cancer allelotype. Cancer Res 53: 2393-2398
6. Coney LR, Tomassetti A, Carayannopoulos L, Frasca V, Kamen BA, Colnaghi MI and Zurawski VR (1991) Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein. Cancer Res 51: 6125-6132
7. Engelstein M, Hudson TJ, Lane JM, Lee MK, Leverone B, Landes GM, Peltonen L, Weber JL and Dracopoli NC (1993) A PCR-based linkage map of human chromosome I, Genomics 15: 251-258
8. Frossl P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, Den Heijer M, Kluijtmans LA, Van Den Heuvel LP and Rozen R (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genet 10: 111-113
9. Goseki N, Yamazaki S, Endo M, Onodera T, Kosaki G, Hibino Y and Kuwahata T (1992) Antitumor effect of methionine-depleting total parenteral nutrition with doxorubicin administration on Yoshida sarcoma-bearing rats. Cancer 69: 1865-1872
10. Goyette P, Sumner JS, Milos R, Duncan AM, Rosenblatt DS, Matthews RG and Rozen R (1994) Human methylenetetrahydrofolale reductase: isolation of cDNA, mapping and mutation identification. Nature Genet 7: 195-200
11. Guo H-Y, Lishko VK, Herrera H, Groce A, Kubota T and Hoffman RM (1993) Therapeutic tumor-specific cell cycle block induced by methionine starvation in vivo. Cancer Res 53: 5676-5679
12. Henderson GB (1990) Folate-binding proteins. Annu Rev Nutr 10: 319-335
13. Hoffman RM (1984) Altered methionine metabolism, DNA methylation and oncogene expression in carcinogenesis. A review and synthesis. Biochim Biophys Acta 738: 49-87
14. Hsu SM, Raine L and Fanger HA (1981) A comparative study of the peroxidase-antiperoxidase method and avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol 75:734-738
15. Jacobsen SJ, North JA, Appaji Rao N and Mangum JH (1977) 5-Methyltetrahydrofolate: synthesis and utilization in normal and SV40-transformed BHK-21 cells. Biochem Biophys Res Commun 76: 46-53
16. Jenkins RB, Bartell D, Jr, Stalboerger P, Persons D, Dahl RJ, Podratz K, Keeney G and Hartmann L (1993) Cytogenetic studies of epithelial ovarian carcinoma. Cancer Genet Cytogenet 71: 76-86
17. Kamen BA and Capdevila A (1986) Receptor-mediated folate accumulation is regulated by the cellular folate content. Proc Natl Acad Sci USA 83: 5983-5987
18. Kane MA, Elwood PC, Portillo RM, Antony AC, Najfeld V, Finley A, Waxman S and Kolhouse JF (1988) Influence on immunoreactive folate-binding proteins of extracellular folate concentration in cultured human cells. J Clin Invest 81: 1398-1406
19. Mäkelä TP, Hellsten E, Vesa J, Alitalo K and Peltonen L (1992) An Alu variable poly A repeat polymorphism upstream of L-myc at 1p.32. Hum Mol Genet 1: 217
20. Matsue H, Rothberg KG, Takashima A, Kamen BA, Anderson RG and Lacey SW (1992) Folate receptor allows cells to grow in low concentrations of 5-methyltetrahydrofolate. Proc Natl Acad Sci USA 89: 6006-6009
21. Matthews RG (1986) Methylenetetrahydrofolate reductase from pig liver. Methods Enzymol 122: 372-381
22. Miotti S, Canevari S, Menard S, Mezzanzanica D, Porro G, Pupa SM, Regazzoni M, Tagliabue E and Colnaghi MI (1987) Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity. Int J Cancer 39: 297-303
23. Miotti S, Facheris P, Tomassetti A, Bottero F, Bottini C, Ottone F, Colnaghi MI. Bunni MA, Priest DG and Canevari S (1995) Growth of ovarian-carcinoma cell lines at physiological folate concentration: effect on folate-binding protein expression in vitro and in vivo. Int J Cancer 63: 395-401
24. Osborne RJ and Leech V (1994) Polymerase chain reaction allelotyping of human ovarian cancer. Br J Cancer 69: 429-438
25. Patel MS, Mankoo BS and Brickell PM (1992) A polymorphic microsatellite repeat is located close to the promoter region of the c-fgr proto-oncogene (FGR) at chromosome 1p36.2-p36.1. Hum Mol Genet 1: 65
26. Ross JF, Chaudhuri PK and Ratnam M (1994) Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer 73: 2432-2443
27. Sato T, Saito H, Morita R, Koi S, Lee JH and Nakamura Y (1991) Allelotype of human ovarian cancer. Cancer Res 51: 5118-5122
28. Shane B (1989) Folylpolyglutamate synthesis and role in the regulation of one-carbon metabolism. Vitam Horm 45: 263-335
29. Thompson FH, Emerson J, Alberts D, Liu Y, Guan XY, Burgess A, Fox S, Taetle R, Weinstein R, Makar R, Powell D and Trent J (1994) Clonal chromosome abnormalities in 54 cases of ovarian carcinoma. Cancer Genet Cytogenet 73: 33-45
30. Veggian R, Fasolato S, Menard S, Minucci D, Pizzetti P, Regazzoni M, Tagliabue E and Colnaghi MI (1989) Immunohistochemical reactivity of a monoclonal antibody prepared against human ovarian carcinoma on normal and pathological female genital tissues. Tumori 75: 510-513
31. Viel A, Maestro R, Toffoli G, Grion G and Boiocchi M (1990) c-myc overexpression is a tumor-specific phenomenon in a subset of human colorectal carcinomas. J Cancer Res Clin Oncol 116: 288-294
32. Viel A, Giannini F, Capozzi E, Canzonieri V, Scarabelli C, Gloghini A and Boiocchi M (1994) Molecular mechanisms possibly affecting WTI function in human ovarian tumors. Int J Cancer 57: 515-521
33. Viel A, Dall'Agnese L, Canzonieri V, Sopracordevole F, Capozzi E, Carbone A, Visentin MC and Boiocchi M (1995) Suppressive role of the metastasis-related nm23-H1 gene in human ovarian carcinomas: association of high messenger RNA expression with lack of lymph node metastasis. Cancer Res 55: 2645-2650
34. Yang Feng TL, Han H, Chen KC, Li SB, Claus EB, Carcangiu ML, Chambers SK, Chambers JT and Schwartz PE (1993) Allelic loss in ovarian cancer. Int J Cancer 54: 546-551
35. Zhou J, Kang SS, Wong PW, Fournier B and Rozen R (1990) Purification and characterization of methylenetetrahydrofolate reductase from human cadaver liver. Biochem Med Metab Biol 43: 234-242